Biotech IPO Calendar
The BioPharmCatalyst Biotech Stock IPO Calendar gives a brief rundown of upcoming biotech initial public offerings.
The Historical Biotech IPO Database below tracks most listings over at least the previous 12 months.
*****
As readers will note below, IPOs in the biotech space can surge over 300% within just a year or two. Conversely, it is not uncommon to see stocks also lose over half their value.
Filter by offer date, IPO price and return to date.
As of mid-September, 2017, 37 of the 62 (60%) of Healthcare IPOs since 2016 have exhibited a positive return.
10 IPOs have shown returns of over 100% while FIVE have seen the value of their company fall by over half.
For a full list of over 450 biotech and pharma companies listed on BioPharmCatalyst we suggest you visit the Biotech Stocks page to search for your ticker of choice.
Upcoming catalysts that are often responsible for the high volatility in such stocks can be found in the BioPharmCatalyst FDA Calendar.
*****
BioPharmCatalyst Premium users have access to the FULL list of approximately 650-750 events through to 2023. A personalized FDA Calendar and screener allows users to filter through drug indications and other options.
Access to BioPharmCatalyst Premium is available HERE.
*****
Data generously supplied by IPOScoop.com
| Ticker | Company | Company lead managers | Shares | Estimated volume | Expected trade date |
|---|---|---|---|---|---|
| ALZH | Alzheon | Citigroup/Piper Jaffray | 5 Million | 70 Million | 04/23/2018 |
| MREO | Mereo BioPharma Group plc | Cowen/ BMO Capital Markets/ RBC Capital Markets | 2.83 Million | 49.9 Million | 04/23/2018 |
| TLC | Taiwan Liposome Company, Ltd | Cantor | 4.69 Million | 36.3 Million | 04/26/2018 |
| ASLN | ASLAN Pharmaceuticals Ltd. | Leerink Partners/ Piper Jaffray | 7.5 Million | 60.37 Million | 05/03/2018 |
Historical IPO Database
Last 61 IPO's
| index | Ticker | Company | IPO price | Price after first day | Current price | Return | Offer date |
|---|---|---|---|---|---|---|---|
| 1 | MOR | MorphoSys AG | $25.04 | $26.31 | N/A | 0.00% | 04/19/2018 |
| 2 | SURF | Surface Oncology | $15.00 | $13.33 | $13.81 | -7.93% | 04/19/2018 |
| 3 | GNPX | Genprex | $5.00 | $4.70 | $4.28 | -14.40% | 03/29/2018 |
| 4 | UMRX | Unum Therapeutics | $12.00 | $11.11 | $11.98 | -0.17% | 03/29/2018 |
| 5 | FIXX | Homology Medicines | $16.00 | $18.66 | $20.40 | 27.50% | 03/28/2018 |
| 6 | POLY | PolyPid Ltd. | N/A | N/A | N/A | 0.00% | 03/23/2018 |
| 7 | RCUS | Arcus Biosciences | $15.00 | $17.00 | $16.30 | 8.67% | 03/15/2018 |
| 8 | BTAI | BioXcel Therapeutics | $11.00 | $11.03 | $9.28 | -15.64% | 03/08/2018 |
| 9 | BFRA | Biofrontera AG | $9.88 | $12.18 | $12.18 | 23.28% | 02/14/2018 |
| 10 | MOTS | Motus GI Holdings | $5.00 | $4.38 | $4.35 | -13.00% | 02/14/2018 |
| 11 | EOLS | Evolus | $12.00 | $11.50 | $7.95 | -33.75% | 02/08/2018 |
| 12 | SLGL | Sol-Gel Technologies | $12.00 | $13.64 | $9.89 | -17.58% | 02/01/2018 |
| 13 | ENTX | Entera Bio Ltd. | N/A | N/A | N/A | 0.00% | 01/29/2018 |
| 14 | SLDB | Solid Biosciences | $16.00 | $22.62 | $12.48 | -22.00% | 01/26/2018 |
| 15 | TORC | resTORbio | $15.00 | $16.88 | $8.77 | -41.53% | 01/26/2018 |
| 16 | ARMO | ARMO BioSciences | $17.00 | $29.74 | $28.26 | 66.24% | 01/26/2018 |
| 17 | EYEN | Eyenovia | $10.00 | N/A | $8.43 | -15.70% | 01/25/2018 |
| 18 | MNLO | Menlo Therapeutics | $17.00 | $28.71 | $8.83 | -48.06% | 01/25/2018 |
| 19 | DNLI | Denali Therapeutics | $18.00 | $21.45 | $19.77 | 9.83% | 12/08/2017 |
| 20 | ODT | Odonate Therapeutics | $24.00 | $23.00 | $20.63 | -14.04% | 12/07/2017 |
| 21 | QTRX | Quanterix | $15.00 | $17.47 | $17.53 | 16.87% | 12/07/2017 |
| 22 | SCPH | scPharmaceuticals | $14.00 | $14.10 | $10.19 | -27.21% | 11/17/2017 |
| 23 | ASNS | Arsanis | $10.00 | $14.03 | $15.51 | 55.10% | 11/16/2017 |
| 24 | APLS | Apellis Pharmaceuticals | $14.00 | $14.03 | $24.52 | 75.14% | 11/09/2017 |
| 25 | IFRX | Fireman B.V. | $15.00 | $14.99 | $38.77 | 158.47% | 11/08/2017 |
| 26 | ALNA | Allena Pharmaceuticals | $14.00 | $9.98 | $13.88 | -0.86% | 11/02/2017 |
| 27 | SPRO | Spero Therapeutics | $14.00 | $13.25 | $12.91 | -7.79% | 11/02/2017 |
| 28 | EYE | National Vision Holdings | $22.00 | $27.83 | $31.61 | 43.68% | 10/26/2017 |
| 29 | OPTN | OptiNose | $16.00 | $19.00 | $20.14 | 25.88% | 10/13/2017 |
| 30 | HAIR | Restoration Robotics | $7.00 | $9.92 | $5.08 | -27.43% | 10/12/2017 |
| 31 | KIDS | OrthoPediatrics | $13.00 | $19.72 | $19.71 | 51.62% | 10/12/2017 |
| 32 | RYTM | Rhythm Pharmaceuticals | $17.00 | $30.00 | $22.19 | 30.53% | 10/05/2017 |
| 33 | DCPH | Deciphera Pharmaceuticals | $17.00 | $17.65 | $24.23 | 42.53% | 09/28/2017 |
| 34 | NITE | Nightstar Therapeutics Ltd. | $14.00 | $24.00 | $14.46 | 3.29% | 09/28/2017 |
| 35 | NCNA | NuCana plc | $15.00 | $16.15 | $23.64 | 57.60% | 09/28/2017 |
| 36 | CELC | Celcuity | $9.50 | $14.29 | $17.41 | 83.26% | 09/20/2017 |
| 37 | KRYS | Krystal Biotech | $10.00 | $10.64 | $10.10 | 1.00% | 09/20/2017 |
| 38 | ZLAB | Zai Lab Ltd. | $18.00 | $27.93 | $20.94 | 16.33% | 09/20/2017 |
| 39 | CMTA | Clementia Pharmaceuticals | $15.00 | $16.35 | $17.63 | 17.53% | 08/02/2017 |
| 40 | SNNA | Sienna Biopharmaceuticals | $15.00 | $19.25 | $20.04 | 33.60% | 07/27/2017 |
| 41 | PETQ | PetIQ | $16.00 | $23.32 | $23.01 | 43.81% | 07/21/2017 |
| 42 | KALA | Kala Pharmaceuticals | $15.00 | $18.49 | $16.00 | 6.67% | 07/20/2017 |
| 43 | AKCA | Akcea Therapeutics | $8.00 | $9.48 | $26.18 | 227.25% | 07/14/2017 |
| 44 | CODX | Co-Diagnostics | $6.00 | $5.81 | $2.00 | -66.67% | 07/12/2017 |
| 45 | DOVA | Dova Pharmaceuticals | $17.00 | $19.81 | $25.33 | 49.00% | 06/29/2017 |
| 46 | ALRN | Aileron Therapeutics | $15.00 | $10.80 | $5.84 | -61.07% | 06/29/2017 |
| 47 | MRSN | Mersana Therapeutics | $15.00 | $14.00 | $16.67 | 11.13% | 06/28/2017 |
| 48 | ATXI | Avenue Therapeutics | $6.00 | $8.25 | $4.35 | -27.50% | 06/27/2017 |
| 49 | ATNX | Athenex | $11.00 | $12.56 | $16.30 | 48.18% | 06/14/2017 |
| 50 | GTHX | G1 Therapeutics | $15.00 | $15.00 | $38.93 | 159.53% | 05/17/2017 |
| 51 | OVID | Ovid Therapeutics | $15.00 | $12.25 | $9.98 | -33.47% | 05/05/2017 |
| 52 | BHVN | Biohaven Pharmaceutical Holding | $17.00 | $17.50 | $27.18 | 59.88% | 05/04/2017 |
| 53 | URGN | UroGen Pharma Ltd. | $13.00 | $13.98 | $56.85 | 337.31% | 05/04/2017 |
| 54 | ZYME | Zymeworks | $13.00 | $13.00 | $11.98 | -7.85% | 04/28/2017 |
| 55 | TOCA | Tocagen | $10.00 | $12.45 | $10.41 | 4.10% | 04/13/2017 |
| 56 | BYSI | BeyondSpring | $20.00 | $16.80 | $31.10 | 55.50% | 03/09/2017 |
| 57 | JNCE | Jounce Therapeutics | $16.00 | $17.25 | $19.46 | 21.63% | 01/27/2017 |
| 58 | ANAB | AnaptysBio | $15.00 | $17.00 | $91.67 | 511.13% | 01/26/2017 |
| 59 | OBSV | ObsEva SA | $15.00 | $11.65 | $13.39 | -10.73% | 01/26/2017 |
| 60 | SBPH | Spring Bank Pharmaceuticals | $12.00 | $11.10 | $14.27 | 18.92% | 05/06/2016 |
| 61 | GI | EndoChoice Holdings (ECPM Holdings) | $15.00 | $17.00 | $0.02 | -99.87% | 06/05/2015 |